South Texas Health Care System, San Antonio, TX Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00708799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

South Texas Health Care System, San Antonio, TX

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Nephropathies (Phase 2)

Kidney Diseases (Phase 2)

Proteinuria (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6